The INTERLACE trial has revealed that adding short-course induction chemotherapy to chemoradiotherapy significantly improves ...

To facilitate further research, the EMBL team released the Microbial Load Predictor (MLP) tool, which is freely available for ...

Isabel A Hujoel, University of Washington, USA, explained that given the known potential of ARBs to cause enteropathy ...

Discover a study where findings suggest that priority should be placed on identifying and managing autoimmune and ...

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study. Read more.

Discover how machine learning predicts successful discontinuation of renal therapy in critically ill patients with acute ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Novartis has claimed the top spot in the 2024 Access to Medicine Index, displacing GSK after 16 consecutive years at the top.

A recent study explores how MYCN-driven neuroblastoma hijacks the m6A modification process to prevent proper cell ...